Document Detail

Three-year outcome of endovascular treatment of superficial femoral artery occlusion.
MedLine Citation:
PMID:  11177146     Owner:  NLM     Status:  MEDLINE    
HYPOTHESIS: Patency after primary percutaneous transluminal angioplasty (PTA) and stenting of superficial femoral artery (SFA) occlusions is better than historical experience with PTA alone. DESIGN: Consecutive case series of primary PTA with stenting, and follow-up with duplex imaging every 6 months (mean +/- SD follow-up, 32 +/- 15 months). SETTING: Veterans Affairs medical center. PATIENTS AND METHODS: Patients were 57 previously untreated men with 71 limbs having chronic atherosclerotic SFA occlusion with suprageniculate reconstitution and patent tibial runoff. Critical ischemia (Society for Vascular Surgery [SVS] category, 4-6) was present in 7 (10%), the remainder had intermittent claudication only (SVS, 1-3). INTERVENTIONS: Guidewire recanalization followed by PTA, Wallstent deployment, and adjunctive thrombolysis as necessary; 19 limbs (27%) required thrombolysis to manage periprocedural thrombosis. MAIN OUTCOME MEASURES: Cumulative patency, limb salvage, and complications. RESULTS: Length (mean +/- SD) of occlusion was 14.4 +/- 9.9 cm. Length of stented artery was 24.3 +/- 11.1 cm. Ankle brachial index increased from 0.59 +/- 0.14 to 0.86 +/- 0.16 (P<.001) after stenting. One- and 3-year patencies were as follows: primary, 54.6% +/- 6.3% and 29.9% +/- 6.6%; assisted primary, 72.3% +/- 5.6% and 59.0% +/- 6.8%; and secondary, 81.6% +/- 4.8% and 68.3% +/- 6.5%. Three-year secondary patency when periprocedural thrombolysis was required was 35.7% +/- 12.5% compared with 70.6% +/- 7.4% for limbs not requiring periprocedural thrombolysis (P=.02); the differences in occlusion length and severity of ischemia were not significant between these 2 groups. Limbs undergoing adjunctive PTA during angiography 6 to 12 months after initial stenting had 63.0% +/- 13.3% patency at 3 years compared with 100% patency in limbs not requiring PTA at 6 to 12 months angiography (P=.046). Periprocedural mortality and morbidity were 2.8% and 15.5%, respectively. Three of the 7 limbs with critical ischemia underwent amputation during follow-up compared with 2 (3%) of 64 limbs with functional ischemia (chi(2) test, P<.006). A mean of 1.8 endovascular interventions per limb were performed. CONCLUSIONS: Percutaneous transluminal angioplasty and stenting yielded higher patency rates than historical controls undergoing PTA alone. When periprocedural thrombolysis is required, subsequent patency appears to be significantly worse. Poor results after PTA and stenting of limbs with critical ischemia and the need for additional endovascular therapy limit the technique's utility.
I L Gordon; R M Conroy; M Arefi; J M Tobis; E A Stemmer; S E Wilson
Related Documents :
16732446 - The influence of the ipsilateral superficial femoral artery on iliac angioplasty.
12053496 - Role of prolonged intravenous heparin in unstable angina patients prior to coronary ang...
20799016 - Technical success rates and long-term patency of endovascular treatment for occluded na...
18992666 - Infrainguinal atherectomy: a retrospective review of a single-center experience.
22530166 - The prognostic significance of the timing of total enteral feeding in traumatic brain i...
14709686 - Alteplase for treatment of occluded peripherally inserted central catheters: safety and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of surgery (Chicago, Ill. : 1960)     Volume:  136     ISSN:  0004-0010     ISO Abbreviation:  Arch Surg     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-02-22     Completed Date:  2001-04-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9716528     Medline TA:  Arch Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  221-8     Citation Subset:  AIM; IM    
Division of Vascular Surgery, University of California-Irvine, Medical Center, 101 City Dr, Orange, CA 92868, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Balloon*
Arteriosclerosis / therapy*
Femoral Artery*
Follow-Up Studies
Plasminogen Activators / therapeutic use
Thrombolytic Therapy*
Time Factors
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use
Vascular Patency / physiology
Reg. No./Substance:
EC 3.4.21.-/Plasminogen Activators; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and preventi...
Next Document:  Increased resource use associated with catheter-related bloodstream infection in the surgical intens...